Protein S protects against allergic bronchial asthma by modulating Th1/Th2 balance
- 7 March 2020
- Vol. 75 (9), 2267-2278
- https://doi.org/10.1111/all.14261
Abstract
Background Bronchial asthma is a chronic disease characterized by inflammation, obstruction and hyperresponsiveness of the airways. There is currently no curative therapy for asthma. Type 2 helper T cell response plays a critical role in the pathogenesis of the disease. Protein S is a glycoprotein endowed with anticoagulant, anti‐inflammatory and anti‐apoptotic properties. Whether protein S can suppress bronchial asthma and be useful for its therapy is unknown. Methods To address this question here we compared the development of allergen‐associated bronchial asthma between wild type and protein S‐overexpressing transgenic mice. Mice were sensitized and challenged with ovalbumin. We also evaluated the circulating levels of total and active protein S in patients with bronchial asthma and healthy controls. Results The circulating level of total protein S and of its active form was significantly decreased in patients with bronchial asthma compared to controls. Allergic protein S transgenic mice showed a significant reduction of airway hyperresponsiveness, lung tissue inflammatory cell infiltration, lung levels of Th2 cytokines and IgE compared to their wild type counterparts. Administration of exogenous human protein S also decreased airway hyperresponsiveness and Th2‐mediated lung inflammation in allergic wild‐type mice compared to their untreated mouse counterparts. Human protein S significantly shifted the Th1/Th2 balance to Th1 and promoted the secretion of Th1 cytokines (IL‐12, tumor necrosis factor‐α) from dendritic cells. Conclusions These observations suggest the strong protective activity of protein S against the development of allergic bronchial asthma implicating its potential usefulness for the disease treatment.Keywords
This publication has 35 references indexed in Scilit:
- TNFR2 maintains adequate IL-12 production by dendritic cells in inflammatory responses by regulating endogenous TNF levelsInnate Immunity, 2013
- Dose‐dependent differential effects of thrombin in allergic bronchial asthmaJournal of Thrombosis and Haemostasis, 2013
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2013
- AsthmaPublished by Elsevier BV ,2011
- Allergic Asthma: Influence of Genetic and Environmental FactorsJournal of Biological Chemistry, 2011
- Costs of asthma in the United States: 2002-2007Journal of Allergy and Clinical Immunology, 2011
- Direct effects of protein S in ameliorating acute lung injuryJournal of Thrombosis and Haemostasis, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Differential Effects of Endogenous and Exogenous Interferon- γ on Immunoglobulin E, Cellular Infiltration, and Airway Responsiveness in a Murine Model of Allergic AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992